- Coronavirus (COVID-19) UpdateThe Centers for Disease Control and Prevention (CDC) is responding to an outbreak of respiratory disease caused by a novel (new) coronavirus that was first detected in China.Read more ...
- CMTA Funds Cutting-Edge Gene Editing Studies for Type 2 CMTDrs. Bruce Conklin and Luke Judge will use a $653,000 grant from the CMTA to develop the gene-editing technique known as CRISPR for application to CMT2A, 2E and 2F.Read more ...
- The 2020 Winter CMTA ReportBe the Change: From attitude to exercise to research, in 2020 our CMTA family is committed to be the change we want to see in the world of CMT.Read more ...
- David Coldiron Joins CMTA Board of DirectorsThe Charcot-Marie-Tooth Association (CMTA), the national patient advocacy organization leading CMT research, today announced the appointment of David Coldiron to its Board of Directors.Read more ...
- A Message from Patients to PatientsAs you’ll learn from watching this video by two young members of our CMT family, tiredness, exhaustion, fatigue and “sluggishness” are all part of having CMT.Read more ...